Scientists have uncovered a toxic alliance between Aβ and fibrinogen that may explain how Alzheimer’s disease begins. The two ...

A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...

Alzheimer's disease is a progressive neurological disorder characterised by memory loss and cognitive decline, caused by ...

The drug, lecanemab, was approved by Health Canada this week. It is the first treatment available in Canada to focus on the ...

A study published in 2023 found that using sleeping pills to get some shut-eye could reduce the buildup of toxic clumps of ...

Doug Whitney, 76, carries a rare PSEN2 genetic mutation that causes early-onset Alzheimer's but shows no cognitive decline ...

“By using a ‘rule out’ initial tool in the primary care setting, we can help people who are not living with Alzheimer’s get ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Have you ever forgotten something so simple and mundane like what you ate the other day repeatedly? If the answer is yes, ...

The effectiveness of eye-tracking technology in identifying people who have a genetic tendency to Alzheimer's disease, years ...

A group of researchers have identified a warning sign of Alzheimer's disease that can appear 25 years before other symptoms - ...

TORONTO – Health Canada has authorized a drug shown to slow the progression of Alzheimer’s disease.   Lecanemab is the first ...